Weighted Average Number of Shares Outstanding, Basic of INFINITY PHARMACEUTICALS, INC. from 30 Sep 2011 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: shares
- Description
- Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2011 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2023 was 89,885,492, a 0.81% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 89,247,785, a 4.3% increase from 2021.
- INFINITY PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 85,597,264, a 43% increase from 2020.
- Source SEC data
- View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 89,885,492 | +723,715 | +0.81% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 | |
| Q1 2023 | 89,413,486 | +258,175 | +0.29% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 | |
| Q4 2022 | 89,247,785 | +3,650,521 | +4.3% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY | |
| Q3 2022 | 89,392,079 | +625,167 | +0.7% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 | |
| Q2 2022 | 89,161,777 | +499,843 | +0.56% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 | |
| Q1 2022 | 89,155,311 | +13,427,135 | +18% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 | |
| Q4 2021 | 85,597,264 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY | |||
| Q3 2021 | 88,766,912 | +28,260,539 | +47% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 14 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | 88,661,934 | +31,219,602 | +54% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 09 Aug 2022 | 2022 | Q2 | |
| Q1 2021 | 75,728,176 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 03 May 2022 | 2022 | Q1 | |||
| Q3 2020 | 60,506,373 | +3,477,403 | +6.1% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 02 Nov 2021 | 2021 | Q3 | |
| Q2 2020 | 57,442,332 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 27 Jul 2021 | 2021 | Q2 | |||
| Q3 2019 | 57,028,970 | +177,159 | +0.31% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 30 Oct 2019 | 2019 | Q3 | |
| Q3 2018 | 56,851,811 | +6,215,983 | +12% | 01 Jul 2018 | 30 Sep 2018 | 10-Q | 30 Oct 2019 | 2019 | Q3 | |
| Q3 2017 | 50,635,828 | +1,052,052 | +2.1% | 01 Jul 2017 | 30 Sep 2017 | 10-Q | 05 Nov 2018 | 2018 | Q3 | |
| Q2 2017 | 50,455,832 | +1,018,770 | +2.1% | 01 Apr 2017 | 30 Jun 2017 | 10-Q | 03 Aug 2017 | 2017 | Q2 | |
| Q4 2016 | 50,099,153 | +871,248 | +1.8% | 01 Oct 2016 | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q3 2016 | 49,583,776 | +395,333 | +0.8% | 01 Jul 2016 | 30 Sep 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q2 2016 | 49,437,062 | +361,031 | +0.74% | 01 Apr 2016 | 30 Jun 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q1 2016 | 49,339,888 | +400,505 | +0.82% | 01 Jan 2016 | 31 Mar 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q4 2015 | 49,227,905 | +438,988 | +0.9% | 01 Oct 2015 | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY | |
| Q3 2015 | 49,188,443 | +555,555 | +1.1% | 01 Jul 2015 | 30 Sep 2015 | 10-K | 14 Mar 2017 | 2016 | FY | |
| Q2 2015 | 49,076,031 | +532,178 | +1.1% | 01 Apr 2015 | 30 Jun 2015 | 10-K | 14 Mar 2017 | 2016 | FY | |
| Q1 2015 | 48,939,383 | +590,616 | +1.2% | 01 Jan 2015 | 31 Mar 2015 | 10-K | 14 Mar 2017 | 2016 | FY | |
| Q4 2014 | 48,788,917 | 01 Oct 2014 | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |||
| Q3 2014 | 48,632,888 | +579,949 | +1.2% | 01 Jul 2014 | 30 Sep 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |
| Q2 2014 | 48,543,853 | 01 Apr 2014 | 30 Jun 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |||
| Q1 2014 | 48,348,767 | 01 Jan 2014 | 31 Mar 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |||
| Q3 2013 | 48,052,939 | +16,013,073 | +50% | 01 Jul 2013 | 30 Sep 2013 | 10-Q | 10 Nov 2014 | 2014 | Q3 | |
| Q4 2012 | 40,855,124 | 01 Oct 2012 | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |||
| Q3 2012 | 32,039,866 | +5,373,534 | +20% | 01 Jul 2012 | 30 Sep 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |
| Q2 2012 | 27,061,435 | 01 Apr 2012 | 30 Jun 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |||
| Q1 2012 | 26,776,856 | 01 Jan 2012 | 31 Mar 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |||
| Q3 2011 | 26,666,332 | 01 Jul 2011 | 30 Sep 2011 | 10-Q | 06 Nov 2012 | 2012 | Q3 |
INFINITY PHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | 89,247,785 | +3,650,521 | +4.3% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2021 | 85,597,264 | +25,739,404 | +43% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2020 | 59,857,860 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.